Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Comparison of an automated weaning programme and a standard clinical weaning protocol for weaning critically ill patients
ISRCTN ISRCTN82559457
ClinicalTrials.gov identifier
Public title Comparison of an automated weaning programme and a standard clinical weaning protocol for weaning critically ill patients
Scientific title Comparison of an automated weaning programme and a standard clinical weaning protocol for weaning critically ill patients: a randomised controlled trial
Acronym N/A
Serial number at source N0013154743
Study hypothesis Will the use of an automated weaning system shorten the duration of mechanical ventilation, and will this be associated with reduced ventilator-associated complications e.g. pneumonia, tracheostomy?

Please note the following changes made to this ISRCTN record as of 10/12/2007:
1. The anticipated end date has been updated from 01/12/2005 to 31/12/2008
2. The target number of participants has been updated from 100 to 500

Please note the following amendments made to this ISRCTN record as of 13/02/2009:
1. Scientific title has been added.
2. The anticipated end date has been updated from 31/12/2008 to 30/06/2010
3. The sponsor has been corrected from "Fresenius Kabi Deutschland GmbH (Germany)" to "Guy's and St. Thomas' NHS Foundation Trust (UK)". This is due to an error in initial information provided for this ISRCTN record.
Lay summary
Ethics approval St Thomas' Hospital Research Ethics Committee
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Process of weaning from mechanical ventilation
Participants - inclusion criteria Added as of 10/12/2007:
Major entry criteria (suspected or proven infection, presence of a systemic response to the infection within the 48-hour period immediately preceding enrolment into the study, have or have had one or more sepsis-induced organ failures within the 48-hour period immediately preceding enrolment into the study).
1. Age >=18 years
2. Acute Physiology and Chronic Health Evaluation II (APACHE II) score =10
3. Precipitating injury (surgery, trauma, hypovolemia, episode of infection or sepsis) occurred within the last 48 hours before Intensive Care Unit (ICU) entry
4. Expected Length Of Stay (LOS) in the ICU >3 days
5. Indication for enteral nutrition for 5-10 days
6. Start of nutritional therapy with Intestamin or control supplement within 24 hours after inclusion criteria are fulfilled
Participants - exclusion criteria 1. Under 18 years of age
2. Requirement for high doses of vasopressor
3. Body temperature greater than 39ºC or less than 36ºC
4. GCS = 12 without or with minimal sedation
5. 'Do Not Resuscitate' order or expected short term prognosis
6. Patients chronically ventilated at home with tracheostomy
7. Patients with primary neurological cause of ventilator dependence
8. Pregnancy
9. Prolonged cardiac arrest with poor neurological prognoses
10. Inability to obtain consent from patient or legal representative
Anticipated start date 01/12/2004
Anticipated end date 30/06/2010
Status of trial Completed
Patient information material
Target number of participants 500
Interventions This is a randomised controlled trial comparing the ICU's standard ventilator weaning protocol and the SmartCare automated weaning system. Patients who are assessed as likely to need mechanical ventilation for a period of 48 hours or more will be randomised to be weaned from mechanical ventilation using either the standard protocol or the automated weaning system. Weaning will be initiated when, in the opinion of the clinical team, the patient is sufficiently improved as to be able to tolerate a spontaneous mode of ventilation and has met defined gas exchange and ventilatory support criteria. Once in the weaning phase, weaning will proceed according to the manual or SmartCare algorithms but will be suspended if the patient's clinical condition deteriorates, and re-instituted once the patient has improved sufficiently for weaning to recommence.
Primary outcome measure(s) Time from the initiation of weaning to successful separation of the patient from the ventilator, defined as no longer needing mechanical ventilation for a minimum period of 48 hours.
Secondary outcome measure(s) Added as of 10/12/2007:
1. Mortality (28-day, ICU and hospital, six-months)
2. Infectious complications (e.g. pneumonia, wound infection, abscesses)
3. APACHE II
4. Organ failure-free days
5. LOS in ICU
6. LOS in hospital (intervention until discharge)
7. Duration of antibiotic treatment (antibiotics days)
8. Duration of ventilation (ventilator days)
9. Duration of renal support
Sources of funding Guy's and St. Thomas' NHS Foundation Trust (UK)
Trial website
Publications
Contact name Dr  Richard  Beale
  Address Adult ICU
East Wing
St Thomas' Hospital
Lambeth Palace Road
  City/town London
  Zip/Postcode SE1 7EH
  Country United Kingdom
  Tel +44 (0)20 7188 3038
  Fax +44 (0)20 7960 5842
  Email Richard.Beale@gstt.nhs.uk
Sponsor Guy's and St. Thomas' NHS Foundation Trust (UK)
  Address St Thomas' Hospital
Westminster Bridge Road
  City/town London
  Zip/Postcode SE1 7EH
  Country United Kingdom
  Tel +44 (0)207 188 7188
  Email
  Sponsor website: http://www.guysandstthomas.nhs.uk/
Date applied 30/09/2005
Last edited 13/02/2009
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central